5-fluorouracil skin treatment for stable, localized vitiligo
Part of Skin clinical trials.
This trial tests a medicated skin powder placed on the skin to treat vitiligo that has been stable for at least a year. It may help people with localized vitiligo by trying to bring back normal skin color without changing their care mid-study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have localized, stable vitiligo (not widespread or changing quickly)
- You are older than 10 years
- Your vitiligo patches have stayed the same for at least 1 year
- You have not used vitiligo treatment for at least 6 weeks before starting
- You can agree to join and sign consent (and stay through follow-up)
- Your vitiligo is not on mucous membranes (like inside the mouth or genitals)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called TEV-53408 to see if it can help with vitiligo, a condition that causes white patches on the skin. It may help by restoring skin color, and the study will check how safe and effective it is.
This trial tests a new cream for vitiligo on the face or neck. It aims to see if the cream can help bring color back to white patches.
This study tests a new way to treat vitiligo by combining a topical cream (methotrexate) with a special laser treatment (fractional CO2 laser) on similar patches on both sides of the body. It aims to see if this combination helps repigment the skin better.
This trial tests whether adding a type of light therapy (narrow-band UVB) to a daily pill called ritlecitinib works better than the pill alone for treating vitiligo. It may help if you have non-segmental vitiligo covering a moderate amount of skin.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
This trial tests a daily pill (upadacitinib) to see if it can improve vitiligo after an initial treatment (NECS). It is for people whose vitiligo is stable and covers a limited area.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.